IDEXX Laboratories, Inc.
IDXX
$652.27
$0.160.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.12% | 4.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.12% | 4.63% | |||
| Cost of Revenue | 10.58% | -2.24% | |||
| Gross Profit | 11.45% | 9.24% | |||
| SG&A Expenses | 4.84% | -1.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.00% | -1.55% | |||
| Operating Income | 17.85% | 20.96% | |||
| Income Before Tax | 16.86% | 20.94% | |||
| Income Tax Expenses | 1.42% | 67.52% | |||
| Earnings from Continuing Operations | 21.14% | 12.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.14% | 12.27% | |||
| EBIT | 17.85% | 20.96% | |||
| EBITDA | 16.61% | 18.69% | |||
| EPS Basic | 22.51% | 13.00% | |||
| Normalized Basic EPS | 18.17% | 21.73% | |||
| EPS Diluted | 22.64% | 12.99% | |||
| Normalized Diluted EPS | 18.19% | 21.86% | |||
| Average Basic Shares Outstanding | -1.11% | -0.64% | |||
| Average Diluted Shares Outstanding | -1.13% | -0.75% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||